La Roche-Posay promises 20% firmer skin in 4 hours with this new treatment
Beauty concerns have come a long way. Today, pigmentation spots, loss of firmness and dull skin matter just as much as wrinkles in any skincare routine. It is against this backdrop that La Roche-Posay is preparing to launch a new product designed to address several of these concerns in a single step.
Mela B3 Double Dose: a complete anti-ageing treatment available in September 2026
The brand is launching Mela B3 Double Dose, available from September 2026 in pharmacies. This treatment targets skin affected by age spots and loss of firmness. It promises to act simultaneously on dark marks and the most visible signs of ageing.
To achieve this, La Roche-Posay combines two technologies from L’Oréal laboratories for the very first time: Melasyl and Proxylane. This unprecedented pairing aims to improve the appearance of spots, firmness and overall skin quality all at once. In doing so, the brand answers a clear demand: treating multiple signs of ageing without overcomplicating your routine.
Women are increasingly looking for treatments capable of tackling several concerns at the same time. Rather than stacking product upon product, they want a single, effective step. La Roche-Posay has therefore developed a formula aimed at skin that presents age spots, loss of firmness, uneven tone or a lack of radiance, often all at once.
“Anti-ageing treatments are becoming more comprehensive, now seeking to address multiple needs in a single step.”
A formula built around real consumer needs
This approach reflects a deeper shift in expectations. Mature skin rarely presents just one isolated concern, several signs tend to appear together. A treatment capable of acting on all these fronts at once therefore represents a genuine saving in time and simplicity.
The La Roche-Posay formula is aimed at those who want firmer skin, a more even complexion and visibly reduced spots, without multiplying their steps. What’s more, pharmacy availability provides a trusted setting for consumers who care about the quality of their skincare.
- Targets age spots and loss of skin firmness
- Combines Melasyl and Proxylane for the first time
- Available in pharmacies from September 2026
- Acts on firmness, radiance and skin tone evenness
- Designed to simplify the daily anti-ageing routine
Fast clinical results on firmness and spots
Among the most striking claims is the treatment’s rapid action on firmness. The brand announces skin that is up to 20% firmer after just 4 hours of application. That is a visible result from the very first use, which adds to the appeal of this treatment for women seeking tangible effects.
Over the following weeks, results continue to build. After 8 weeks, clinical studies highlight up to a 30% reduction in age spots. The treatment therefore works both in the short term on firmness and over the longer term on dark marks.
The figures shared by La Roche-Posay also point to an overall improvement in skin quality. After several weeks of use, 78% of women report brighter-looking skin, 62% notice a more even complexion and 76% see a visible improvement in wrinkles, alongside visibly firmer skin.
A treatment that embodies the new generation of anti-ageing formulas
These results position Mela B3 Double Dose as a product that is emblematic of a broader trend. Anti-ageing formulas are now designed to act on multiple signs of ageing simultaneously, and to do so without complicating the daily routine.
This new generation of treatments follows a simple logic: fewer products, greater efficacy. La Roche-Posay is firmly aligned with this movement, with a treatment conceived to be both comprehensive and accessible. Mela B3 Double Dose is shaping up to be one of the most anticipated beauty launches of autumn 2026.
What women can expect from Mela B3 Double Dose day to day
Beyond the numbers, this treatment speaks to a reality many women know well. Watching age spots appear while noticing skin that feels less firm can be a source of real discomfort. Having a single product capable of addressing both concerns is therefore a genuine relief in any routine.
Pharmacy availability also reinforces the product’s credibility. Skincare sold in pharmacies carries a serious, rigorous reputation. On top of that, the guidance of a healthcare professional remains an option for women looking to find the treatment best suited to their skin type.
In practice, Mela B3 Double Dose fits easily into an existing routine. Its action on spots, firmness, radiance and skin tone evenness makes it a versatile treatment. La Roche-Posay is thus offering a concrete answer to the expectations of women who want to take care of their skin without getting lost in a sea of products.
